Consistently, we found that the mRNA expression levels of RUNX2 and MMP1 revealed similar expression pattern, and in particular, those in triple negative breast cancer cell line were significantly higher than in non-triple negative breast cancer cell line (Figure 8A). This evidence concerns the gene RUNX2 and triple-negative breast carcinoma.